Oncology targets, strategies, cancer drug development and personalized medicine
Cancer Meetings and Conferences
Mission Tumor's Cancer Charity of the Month
Website Use Notice
Thursday, November 3, 2011
MDV1300 Making a Mark While Provenge Takes a Deep Plunge
Today San Francisco-based
($MDVN) saw its stock value scale
within a day. This coming on the heels of
losing a huge chunk of its stock value
yesterday is a good example of human psychology.
We reward "optimism" over "cautious behavior."
Read more »
phase 3 trial